Position in ILMN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$50,837,903
-$23,776,675 QoQ
Shares Held
289,131
-52.2% QoQ
Ownership
0.191%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#91
of 932 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Ilex Capital Partners (UK) LLP holds $222,464,235 across 5 Diagnostics & Research names. ILMN ranks #3 (22.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
154,736 | $77,578,440 | |
| 2 | IQV |
Iqvia Holdings Inc.
|
370,977 | $71,680,175 | |
| 3 | ILMN |
Illumina, Inc.
This page
|
289,131 | $50,837,903 | |
| 4 | CRL |
Charles River Laboratories International, Inc.
|
81,193 | $18,413,760 | |
| 5 | RVTY |
Revvity, Inc.
|
35,538 | $3,953,957 |
All Filings in ILMN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,837,903 | 289,131 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $74,614,578 | 605,343 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $38,944,420 | 296,923 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $64,808,192 | 682,407 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,704,493 | 154,119 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,460,649 | 18,410 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||